Director Seth Alpna sold $28,140 worth of shares (2,625 units at $10.72) as part of a pre-agreed trading plan, decreasing direct ownership by 21% to 9,767 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

KROS· Keros Therapeutics Inc.

Health Care

Original source

Director Seth Alpna sold $28,140 worth of shares (2,625 units at $10.72) as part of a pre-agreed trading plan, decreasing direct ownership by 21% to 9,767 units (SEC Form 4) | Quantisnow